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ABSTRACT
Objective: To analyze the socio-demographic profile of reported hepatitis B and immunization against the disease. 
Methods: Study Hepatitis B notification data in the surveillance of a Minas Gerais’ municipality, from 2007 to 
2015, conducted at the Labor Education Program for Health descriptive and analytical statistics, with significance 
level of p<0.05. Results: 132 cases and two deaths were notified. The age of the reported cases ranged from zero 
to 87 years, average 35.8 (± 14.0) years. More frequently for men (52.3%) and with low education (64.8%). Most 
of them did not vaccinate (81.8%) and had positive result of HSBsAg serology (90.1%); immunization was not 
linked to the socio-demographic profile (p>0.05). Conclusion: Age, education and gender were not associated 
with immunization, vaccination schedule and the HSBsAg test. The absence of vaccination among the notified 
suggests need for health education among the population, orienting the possibility of protection by immunization. 
Descriptors: Hepatitis B, Hepatitis B Vaccines, Public Health, Epidemiological Surveillance.
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RESUMO
Objetivo: Analisar o perfil sociodemográfico dos notificados para hepatite 
B e a imunização contra a doença. Métodos: Estudo com dados de 
notificação de hepatite B na vigilância epidemiológica do município de 
Minas Gerais, entre 2007 a 2015, conduzido no Programa de Educação 
pelo Trabalho para a Saúde. Estatística descritiva e analítica, com nível de 
significância p<0,05.  Resultados: Notificaram-se 132 casos e dois óbitos. A 
idade dos notificados variou de zero a 87 anos, média de 35,8 (±14,0) anos. 
Maior frequência para homens (52,3%) e baixa escolaridade (64,8%). A 
maioria não vacinou (81,8%) e teve resultado da sorologia HSBsAg positivo 
(90,1%); a imunização não se associou ao perfil sociodemográfico (p>0,05). 
Conclusão: Idade, escolaridade e sexo não foram associados à imunização, 
ao esquema vacinal ou ao teste HSBsAg. A ausência de vacinação entre os 
notificados sugere a necessidade de educação em saúde junto à população, 
orientando-a sobre possibilidade de proteção pela imunização. 
Descritores: Hepatite B, Vacinas contra Hepatite B, Saúde Pública, 
Vigilância Epidemiológica.
RESUMEN
Objetivo: Analizar el perfil sociodemográfico reportado de hepatitis 
B y la inmunización contra la enfermedad. Métodos: Estudio de datos 
de notificación de la hepatitis B en la vigilancia del municipio de Minas 
Gerais, de 2007 a 2015, realizadas en el Programa de Educación para el 
Trabajo de estadística descriptiva y analítica de la Salud, con un nivel de 
significación de p<0,05. Resultados: 132 casos fueron notificados; dos 
muertes. La edad del reportado varió de cero a 87 años, con una media de 
35,8 (± 14,0) años. Con mayor frecuencia entre los hombres (52,3%) y baja 
educación (64,8%). La mayoría no vacunados (81,8%) y tuvo resultado 
positivo de HSBsAg serología (90,1%); la inmunización no vinculado al 
perfil sociodemográfico (p>0,05). Conclusión: La edad, la educación y el 
sexo no se asociaron con la inmunización, calendario de vacunación y la 
prueba HSBsAg. La ausencia de vacunación entre los notificados sugiere 
la necesidad de educación para la salud entre la población, orientando la 
posibilidad de protección mediante la vacunación. 
Descriptores: Hepatitis B,Vacunas contra Hepatitis B, Salud Pública, 
Vigilancia Epidemiológica.
INTRODUCTION
Hepatitis B is a chronic disease transmitted through skin 
lesions and mucosa, sexual relations, percutaneous exposure 
to needles or other contaminated instruments, blood 
transfusions, dialysis procedures, dental, among others.1
The World Health Organization (WHO) estimates that in 
the world, there are about 325 million people with hepatitis B 
virus (HBV), two million just in Brazil.2-3 Brazil is among the 
countries with high rates of HBV infection and the fatality 
rate of hospitalized patients is 0.8 to 2% and may increase in 
individuals over 40 years old.1
Suspected cases of infection of the disease should be 
reported in epidemiological surveillance and conducted 
tests to confirm or not the contagion, and, if needed, 
initiate the appropriate treatment. Viral hepatitis are 
considered notifiable diseases since 2006.2 After infection, 
the incubation period ranges from 30 to 180 days, and the 
disease divided into acute and chronic phase. The latter 
refers to persistent infection for more than six months.1 The 
chronicity of the disease negatively impacts the quality of life 
of infected individuals, and may cause stress, interfere with 
social relationships and in performing daily tasks. Moreover, 
there is increased risk of hepatic decompensation, cirrhosis, 
hepatocellular carcinoma, among others.3
Prevention of disease is carried out by vaccination, which 
from the 1990s came to be provided free by the Unified Health 
System (SUS). It consists of three doses, the first being applied 
in the first 12-24h life.4 After completing the vaccination 
schedule is interesting that tests be conducted to verify the 
individual seroconversion, or confirm the development of 
sufficient anti-HBs antibodies against hepatitis B.5
The aim of this study was to analyze the demographic 
profile of reported hepatitis B and immunization 
against disease.
METHODS
The research project was approved by the Ethics in 
Research Committee involving human beings of the State 
University of Montes Claros (Unimontes) seem embodied 
nº 437 086, in respect to Resolution 466/2012 of the National 
Council of Health, Ministry of Health and the ethical 
principles of declaration of Helsinki. It was also important 
the institutional consent of the Municipal Department 
of Health, Epidemiological Surveillance sector of the city 
of Montes Claros/Minas Gerais, Brazil. The municipality 
is of medium size, with a population estimated at 390,000 
inhabitants. The study has the documentary design with a 
cross and quantitative approach, and was developed with 
data compulsory reporting forms for hepatitis B between 
2007 and 2015. The research was carried out under the 
Education Program for Working for Health Surveillance in 
Health (PET-HEALTH/VS).
Data collection occurred in September 2015, from a form 
that included the following variables: year of notification, 
sociodemographic notified to health issues, vaccination 
(complete, incomplete or unvaccinated) and results of 
HbsAg serology. For the socio-demographic profile of 
notified people were assessed: gender (female, male), age 
(represented by children life cycle and adolescents up to 
17 years, adults 18-59 years old and older with more than 
60 years) and education (illiterate, complete or incomplete 
1st degree, complete or incomplete 2nd degree, complete or 
incomplete higher education). In Brazil, the first full degree 
is equivalent to nine years of study; a high school education, 
to 12 years of study; the incomplete higher education, for 
more than 12 years, and completed higher level depends 
on the completed course, suffering from years variation for 
the payment (generally four to six years of graduation). For 
statistical analysis it was grouped the categories 2 full degree/
incomplete and complete higher level, and the relative ages of 
the children and adolescents due to the small number of cases 
reported in each of these categories. In addition to the year of 
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the notification and the socio-demographic profile, identified 
the number of deaths among reported for hepatitis B.
Statistical analysis involved descriptive analysis by 
calculating the absolute and percentage values and, crossing 
the variables serology for HBsAg and vaccination schedule 
with the socio-demographic profile of individuals reported 
to hepatitis B by Pearson’s chi square or its alternative 
Likelihood ratio. To compare the average ages of the notified 
people as vaccination schedule, complete, incomplete or 
unvaccinated used the nonparametric Kruskal-Wallis, due 
to non-normality of the data. It was considered for all tests 
the significance level of p <0.05.
RESULTS
Between the period from 2007 to September 2015 were 
reported 132 cases of hepatitis B, with higher prevalence in 
2007 (24.2%) and 2012 (15.2%). In 2015 cases decrease was 
observed, with a total of two cases reported until September 
(Table 1). The death record was reported for two cases, one 
with 31 years old and another with 57, one in 2008 and 
another in 2012. These two cases referred to the male and 
education compatible to the 2nd full extent, for example 12 
years of study.
Table 1 - Distribution of notifications for hepatitis B as the 
year of notification
Year N %
2007 32 24.2
2008 19 14.4
2009 18 13.6
2010 8 6.1
2011 5 3.8
2012 20 15.2
2013 18 13.6
2014 10 7.6
2015 until September 2 1.5
Total 132 100.0
The age range of those reported people ranged from 
zero to 87 years, with a grade average of 35.8 (± 14.0) years. 
The age of up to 26 years was observed in 25% of cases, 50% 
was up to 35 years and 75% were age up to 44 years. Only 
three children aged up to two years, have been reported. The 
teenagers were also in number of three cases, one aged 16 
and two aged 17; adults (18-59 years) accounted for the most 
affected group, with 90.2% of cases and only six elderly (60-
87 years) have been reported.
The predominance of notifications was male, with 52.3%. 
The level of education was recorded in the records of only 
54 people, and most of these (64.8%) had the 2nd grade 
incomplete (Table 2).
Table 2 - Profile of patients with hepatitis B on the gender 
and education
Variable N %
Gender
Female 63 47.7
Male 69 52.3
Total 132 100
Education
2° Grade incomplete 35 64.6
2° Grade complete 16 29.6
Complete college 
education
1 1.9
Incomplete college 
education
2 3.7
Total 54 100.0
The positive results of serology HSBsAg confirmed the 
disease to 90.1% of 121 people who have undergone this 
examination. Crossing the profile of patients with hepatitis B 
with the test result, there was a predominance of positivity in 
men, adults and those with not completed high school, but 
without statistical significance (Table 3).
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Table 3 - HBsAg serology result according to the socio-demographic profile of reported hepatitis B
Serology results: HBsAg
Variable
Reagent Non reactive Total
p
n % n % n %
Gender
Female 53 89,8 6 10,2 59 100,0
0,928Male 56 90,3 6 9,7 62 100,0
Total 109 90,1 12 9,9 121 100,0
Age
Children/Adolescents 5 100,0 0 0,0 5 100,0
0,299
Adults 98 89,1 12 10,9 110 100,0
Elderly 6 100,0 0 0,0 6 100,0
Total 109 90,1 12 9,9 121 100,0
Education
2° Grade incomplete 29 90,6 3 9,4 32 100,0
0,103
2° Grade complete or 
higher
17 100,0 0 0,0 17 100,0
Total 46 93,9 3 6,1 49 100,0
The record about vaccination or not against hepatitis B was identified in 66 reporting forms. In these, 81.8% of reported did 
not receive the vaccine, 10.6% received the full vaccination schedule of three doses and 7.6% did not complete the vaccination 
schedule. The average age of the notified according to the vaccination schedule, the average age for those with full scheme 
was 31.4 years (±13.25), incomplete was 32.0 years (±19.41) and unvaccinated the average was 38.8 years (±14.99), with no 
significant difference between the average age (p = 0.195). The complete vaccine scheme showed a higher frequency among 
male reported in adults and between those who have the 2nd degree incomplete, with no statistical difference (Table 4).
Table 4 - Vaccination schedule for hepatitis B as socio-demographic profile of the notified
Vaccination
Sociodemographic 
profile Complete
n (%)
Incomplete
n (%)
Not vaccinated 
n (%)
Total
n (%)
P
Gender
Female 3(7.9) 4(10.5) 31(81.6) 38(100.0)
0.419Male 4(14.3) 1(3.6) 23(82.1) 28(100.0)
Total 7(10.6) 5(7.6) 54(81.8) 66(100.0)
Age
Children/Adolescents 0(0.0) 0(0.0) 2(100.0) 2(100.0)
0.718Adults 7(11.5) 5(8.2) 49(80.3) 61(100.0)
Elderly 0(0.0) 0(0.0) 3(100.0) 3(100.0)
Total 7(10.6) 5(7.6) 54(81.8) 66(100.0)
0.096
Education
2° Grade incomplete 3(14.3) 0(0.0) 18(85.7) 21(100.0)
2° Grade complete or 
higher
0(0.0) 1(9.1) 10(90.9) 11(100.0)
Total 3( 9.4) 1(3.1) 28(87.5) 32(100.0)
DISCUSSION
This article brought the analysis of the results of serology HBsAg and immunization against hepatitis B as the socio-
demographic profile of people reported in the city of Montes Claros/Minas Gerais, from 2007 to 2015. For almost a decade, 
there was a trend decreasing cases between 2007 and 2011, equivalent to 640.0% reduction in reported cases of hepatitis B; 
unlike the period between 2012 and 2014, there was an increase of 400.0%, and again observed a decline from 2012 to 2014 
to 50.0% in the cases.The data suggest that 2015 was the lowest number of cases, as to the month of September only two cases 
had been reported. The reduction of cases reported in the municipal epidemiological surveillance industry can be explained 
by several reasons, such as failure to notify the health units or less contact with the virus or greater control of viral infection 
in the city. It should be noted, there cord of two deaths among cases reported with hepatitis B.
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Hepatitis B is a disease that affects people around the 
world and presents itself as a public health problem, because 
of their ability to become chronic, causing liver cirrhosis 
and hepatocellular carcinoma, it is considered the most 
severe viral hepatitis,6 so it is essential to adopt educational 
measures and prevention, control and treatment of this 
pathology in order to reduce cases.
This study indicated a predominance of males among 
reported for hepatitis B, and also confirmed for HBsAg 
serology was prevalent for men. Corroborating this article, 
a work in Manaus/AM, Brazil, from 1997 to 2001, showed 
a higher prevalence of HBV infection in men, with 70.2% 
of the total.7 Accordingly, another study conducted in the 
state of Pará found predominance of men over women, with 
62.6% of those infected.8  This higher incidence of the disease 
in men reflects a possible increased risk behavior among 
them, hypothetically by contamination through sex with 
multiple partners and lack of protection in this regard.
Diverging expectations regarding gender, a case-
control study in São Mateus/Espírito Santo, Brazil, found 
prevalence of hepatitis B in females. However, if justified in 
the fact that women are more active in the search for medical 
consultations, examinations and greater concern with self-
care and health and, therefore, have been the most diagnosed 
with this disease.9
The route of most common transmission for hepatitis 
B is sexual, therefore, the age group of youth and adults 
who possibly has sexually active would be more exposed 
to contamination with HBV. Thus, one can explain the 
higher number of cases in the adult stage of life in this study. 
Other research done in the country, also confirm the higher 
prevalence in adults, the group between 20 and 40 years old 
were the most affected and that can relate to increased risk of 
infection through sexual intercourse.10,11
The route of most common transmission for hepatitis B 
is sexual, therefore, the age group of youth and adults who 
possibly has sexually active life would be more exposed to 
contamination with HBV. Thus, this can explain the higher 
number of cases in the adult stage of life in this study. 
Other research done in the country, also confirm the higher 
prevalence in adults, the age group between 20 and 40 as the 
most affected and that can relate to increased risk of infection 
through sexual intercourse.6 Unlike the present study, we 
found a very small number of adolescents affected by hepatitis 
B, only three cases in the period of almost a decade.
According to the National Survey conducted by the 
Ministry of Health (MS) in 2011, the percentage positive for 
HBV was 1.1% for ages 10 to 19 years old and 11.6% for the 
age group of 20 to 69 years old.12 The frequency found for 
children and adolescents in this study, was also low (5.3%), as 
well as in the survey conducted between 2001-2011, Paraná, 
who observed small values in the age group of zero to nine 
years, which It reflects the good response to immunization 
performed in children. Already, the higher age groups 
have higher incidences, both for non-vaccination in these 
ages, which were not initially covered by the vaccine basic 
calendar, which implemented the vaccine against HB, but 
also at higher risk of infection through sexual transmission,6 
as previously stated.
Level of education was selected for analysis in this 
study, but it was recorded in only 54 reporting forms HB, 
losing this information for 78 cases. Failure to complete, 
by the health workers, data required in notifications forms 
brings loss and limits the epidemiological study by the lack 
of important information for global characterization of 
the socio-demographic profile of patients with hepatitis B. 
For the valid records, most individuals had not completed 
high school. However, testing for HBsAg positive was not 
associated with low education.
Another study found a correlation between hepatitis B 
with the lowest education. The higher prevalence of HBV 
infection was for residents in rural areas, which can be 
explained by the difficulty of access to health and education 
services for the rural population.9 Survey noted that 29.9% 
of those infected with HBV were illiterate and 70.1% had 
primary education only.13 Thus, we see the need to invest 
in health education, informing the public about the means 
of contamination, prevention and treatment of hepatitis B, 
as the highest prevalence among those with less education, 
in order to enable them to self care against infection from 
hepatitis virus.
Immunisation against HBV was a key factor in reducing 
the prevalence rates of disease worldwide. In this study, only 
66 reporting forms were filled to the topic of vaccination, 
which reflects another failure of professionals responsible 
for notification, bringing limitations in epidemiological 
studies. In addition, there is the bias of memory that can 
interfere with the results of this variable, since the person 
cannot respond correctly to their vaccination status. Among 
the valid records, more than 80.0% of people have not been 
vaccinated against hepatitis B, and the high frequency due to 
the acquired protection effectiveness with vaccination.
The lack of knowledge about the pathology and the 
low perceived susceptibility are factors related to the lack 
of adherence to the vaccine.14 Also, they are among the 
main reasons for not being vaccinated against hepatitis B 
the deficit in training and poor education.15 Thus, it can be 
inferred that the lack of information leads to a cascade effect, 
less adherence to immunization and therefore less protection 
to infection by hepatitis B.
Agreeing with this study, a survey conducted in Campinas/
SP, revealed no differences between the vaccine coverage and 
the profile of the cases analyzed in relation to gender, age, 
family income and education.16 In Brazil, vaccination against 
hepatitis B has been implemented since 1989 by the National 
Immunization Program of the Ministry of Health (PNI/MS). 
Initially, the vaccine was approved for children under one 
year of age in the western Amazon region and later, after ten 
years, for the whole country. Immunization is performed in 
three doses, and its response is satisfactory, since the vaccine 
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is highly immunogenic for over 90% of adults and 95% of 
healthy children and adolescents.6
As a result of vaccination, there was reduction of 
endemicity of hepatitis B from the 1990s, the main way 
to prevent infection with HBV. In this sense, the PNI/MS 
extended immunization for children under 20 years of age. 
However, for those population groups most susceptible to 
infection, from 2011 it was made available to vaccine for the 
age groups between 20 and 24 years and, in 2012, to 29 years of 
age.There are other population groups more vulnerable and, 
therefore, the public health system provides immunization 
against HBV regardless of age for manicures, fire, blood 
donors, garbage collectors, truck drivers and healthcare 
professionals. The PNI/MS adopted vaccination with one 
dose in the first 12 hours of life every newborn, regardless of 
the mother’s serologic stage, as there is baby contamination 
risk during childbirth. Immunisation prevents this vertical 
transmission in 90% of cases and the mother can breastfeed 
your child without the risk of infecting him.6 This measure 
may explain the very small number of children reported in 
the current study.
Also immunization against hepatitis B decreased in 
recent years to HBV infection in health care workers, which 
can be associated with vaccination in this risk group as well 
as adoption of standard precautionary measures.17 However, 
a study conducted with health workers of a hospital in Minas 
Gerais found that most, although immunized against HBV, 
did not seek to confirm the immunization test for anti-
HBs. Not knowing the immune status on the virus of the 
disease, these professionals still at risk of becoming infected 
in the event of an occupational accident with contaminated 
biological material. The highest rate of immunization and 
search for confirmation of the immune status against the 
disease is among younger workers, who possibly had the 
opportunity of updates and information on the relevance of 
this protection in case of biological accident.18
The limitations found in the work, in general, refer to the 
lack of information on topics of notifications chips, which 
can interfere with the global observation of the population 
group studied the municipality.
CONCLUSION
The decrease of cases in the following years, from 2007, 
suggests improvement in the health status of the population 
and the hepatitis B infection in a medium-sized city in Minas 
Gerais, Brazil. Among the reported cases, most people had 
not been vaccinated, or did not receive the full protection 
vaccination schedule against hepatitis B. Despite the injury 
has reached more often males, adults and people with less 
education, this demographic profile was not associated with 
the outcome of HBsAg serology and complete vaccination 
schedule, incomplete or unvaccinated. In order to reduce 
hepatitis B in the population it is essential that health 
professionals and services to invest in prevention and health 
education. Discuss with the population the possibility 
of immunization against the disease is of paramount 
importance. Through the complete vaccination and testing 
to prove the protective response can prevent HBV infection, 
reflecting positively on public health, breaking the chains 
of transmission of this disease. Health education must be 
thought also to health professionals for proper filling of all 
fields of the notification form; because they are fundamental 
in defining the socio-demographic profile of patients with 
hepatitis B and use both for surveillance and for planning 
actions from the assessment and monitoring of data.
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